int	The authors report the case of an infant with confirmed congenital hypothyroidism on <e10> levothyroxine </e10> who experienced a possible drug interaction with <e20> simeticone </e20> .
int	Synergistic interaction between <e10> sunitinib </e10> and <e20> docetaxel </e20> is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.
int	<e10> Melatonin </e10> may interact with the following drugs: <e21> aspirin </e21> and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other <e22> NSAIDs </e22> (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), <e20> fluvoxamine </e20> (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), <e22> beta_blockers </e22> (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), <e20> fluoxetine </e20> (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), <e22> progestin </e22> (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), <e22> benzodiazepenes </e22> and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	<e10> Melatonin </e10> may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta_blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and <e22> corticosteroids </e22> (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids ).
int	Some <e12> anticonvulsants </e12> may interact with <e20> Mephenytoin </e20> .
int	<e10> Mequitazine </e10> can interact with <e22> CNS_depressant </e22> , antichlolinergic , TCA , MAOIs , and alcohol .
int	<e10> Mequitazine </e10> can interact with CNS_depressant , <e22> antichlolinergic </e22> , TCA , MAOIs , and alcohol .
int	<e10> Mequitazine </e10> can interact with CNS_depressant , antichlolinergic , <e22> TCA </e22> , MAOIs , and alcohol .
int	<e10> Mequitazine </e10> can interact with CNS_depressant , antichlolinergic , TCA , <e22> MAOIs </e22> , and alcohol .
int	<e10> Mequitazine </e10> can interact with CNS_depressant , antichlolinergic , TCA , MAOIs , and <e20> alcohol </e20> .
int	<e10> Methscopolamine </e10> may interact with antidepressants ( <e22> tricyclic </e22> type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), <e22> MAO_inhibitors </e22> (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, <e20> phenelzine </e20> , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , <e20> linezolid </e20> , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , <e20> tranylcypromine </e20> , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , <e20> isocarboxazid </e20> , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , <e20> selegiline </e20> , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , <e20> furazolidone </e20> ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), <e20> quinidine </e20> , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , <e20> amantadine </e20> , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , <e22> antihistamines </e22> (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, <e20> diphenhydramine </e20> ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other <e22> anticholinergics </e22> , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , <e20> potassium_chloride </e20> supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, <e20> antacids </e20> , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , <e22> absorbent-type_anti-diarrhea_medicines </e22> (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, <e20> kaolin </e20> - pectin ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - <e20> pectin </e20> ), phenothiazines (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), <e22> phenothiazines </e22> (e,g,, chlorpromazine , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, <e20> chlorpromazine </e20> , promethazine ).
int	<e10> Methscopolamine </e10> may interact with antidepressants ( tricyclic type), MAO_inhibitors (e,g,, phenelzine , linezolid , tranylcypromine , isocarboxazid , selegiline , furazolidone ), quinidine , amantadine , antihistamines (e,g,, diphenhydramine ), other anticholinergics , potassium_chloride supplements, antacids , absorbent-type_anti-diarrhea_medicines (e,g,, kaolin - pectin ), phenothiazines (e,g,, chlorpromazine , <e20> promethazine </e20> ).
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain <e22> antibiotics </e22> (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, <e22> aminoglycosides </e22> , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , <e22> tetracyclines </e22> , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , <e20> bacitracin </e20> , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , <e22> polymyxins </e22> , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , <e20> lincomycin </e20> , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , <e20> clindamycin </e20> , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e20> colistin </e20> , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and <e20> sodium_colistimethate </e20> ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), <e20> magnesium </e20> salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, <e20> lithium </e20> , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local <e22> anesthetics </e22> , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , <e20> procainamide </e20> , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of <e10> nondepolarizing_agents </e10> such as MIVACRON include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and <e20> quinidine </e20> .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain <e22> antibiotics </e22> (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, <e22> aminoglycosides </e22> , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , <e22> tetracyclines </e22> , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , <e20> bacitracin </e20> , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , <e22> polymyxins </e22> , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , <e20> lincomycin </e20> , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , <e20> clindamycin </e20> , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , <e20> colistin </e20> , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and <e20> sodium_colistimethate </e20> ), magnesium salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), <e20> magnesium </e20> salts, lithium , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, <e20> lithium </e20> , local anesthetics , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local <e22> anesthetics </e22> , procainamide , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , <e20> procainamide </e20> , and quinidine .
int	Other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as <e11> MIVACRON </e11> include certain antibiotics (e,g,, aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ), magnesium salts, lithium , local anesthetics , procainamide , and <e20> quinidine </e20> .
int	Gentamicin : Animal data have suggested the possibility of interaction between <e10> perindopril </e10> and <e20> gentamicin </e20> .
int	Concomitant use of <e10> alcohol </e10> with <e20> phentermine_hydrochloride </e20> may result in an adverse drug interaction.
int	Although this has not occurred in in vitro studies with coumarin-type_anticoagulants , interactions with <e12> coumarin-type_anticoagulants </e12> have been reported with <e21> FELDENE </e21> since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type_anticoagulants and other highly protein-bound drugs.
int	Use with Anticholinergics : Because of their mechanism of action, <e12> cholinesterase_inhibitors </e12> have the potential to interfere with the activity of <e22> anticholinergic_medications </e22> .
int	Thus strong inhibitors of cytochrome P4501A2, such as <e10> fluvoxamine </e10> , given concomitantly during administration of <e20> Ropivacaine </e20> , can interact with Ropivacaine leading to increased ropivacaine plasma levels.
int	Concomitant administrations not recommended: - Terfenadine and astemizole : Certain <e12> macrolides </e12> interact with <e20> terfenadine </e20> and astemizole leading to increased serum concentrations of the latter.
int	Concomitant administrations not recommended: - Terfenadine and astemizole : Certain <e12> macrolides </e12> interact with terfenadine and <e20> astemizole </e20> leading to increased serum concentrations of the latter.
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral <e22> contraceptives </e22> , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain <e22> antibiotics </e22> , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain antibiotics , <e20> quinidine </e20> , theophylline , corticosteroids , anticoagulants , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , <e20> theophylline </e20> , corticosteroids , anticoagulants , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , <e22> corticosteroids </e22> , anticoagulants , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , <e22> anticoagulants </e22> , and beta_blockers .
int	<e12> Barbiturates </e12> may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and <e22> beta_blockers </e22> .
int	This is typical of the interaction of <e10> meperidine </e10> and <e22> MAOIs </e22> .
int	<e10> norepinephrine </e10> and dobutamine are incompatible with <e20> sodium_bicarbonate </e20> solution.
int	norepinephrine and <e10> dobutamine </e10> are incompatible with <e20> sodium_bicarbonate </e20> solution.
int	Interactions for <e10> Vitamin_B1 </e10> ( Thiamine ): <e22> Loop_Diuretics </e22> , Oral Contraceptives , Stavudine , Tricyclic_Antidepressants
int	Interactions for <e10> Vitamin_B1 </e10> ( Thiamine ): Loop_Diuretics , Oral <e22> Contraceptives </e22> , Stavudine , Tricyclic_Antidepressants
int	Interactions for <e10> Vitamin_B1 </e10> ( Thiamine ): Loop_Diuretics , Oral Contraceptives , <e20> Stavudine </e20> , Tricyclic_Antidepressants
int	Interactions for <e10> Vitamin_B1 </e10> ( Thiamine ): Loop_Diuretics , Oral Contraceptives , Stavudine , <e22> Tricyclic_Antidepressants </e22>
int	Interactions for Vitamin_B1 ( <e10> Thiamine </e10> ): <e22> Loop_Diuretics </e22> , Oral Contraceptives , Stavudine , Tricyclic_Antidepressants
int	Interactions for Vitamin_B1 ( <e10> Thiamine </e10> ): Loop_Diuretics , Oral <e22> Contraceptives </e22> , Stavudine , Tricyclic_Antidepressants
int	Interactions for Vitamin_B1 ( <e10> Thiamine </e10> ): Loop_Diuretics , Oral Contraceptives , <e20> Stavudine </e20> , Tricyclic_Antidepressants
int	Interactions for Vitamin_B1 ( <e10> Thiamine </e10> ): Loop_Diuretics , Oral Contraceptives , Stavudine , <e22> Tricyclic_Antidepressants </e22>
int	<e10> Trilostane </e10> may interact with <e20> aminoglutethimide </e20> or mitotane (causing too great a decrease in adrenal function).
int	<e10> Trilostane </e10> may interact with aminoglutethimide or <e20> mitotane </e20> (causing too great a decrease in adrenal function).
